Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, Cataldo I, Covelli C, Mangia A, Guido M.
Pathologica. 2021 Jun;113(3):170-184. doi: 10.32074/1591-951X-245.
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review.
Goubault P, Brunel T, Rode A, Bancel B, Mohkam K, Mabrut JY.
J Visc Surg. 2019 Sep;156(4):319-328. doi: 10.1016/j.jviscsurg.2019.02.006. Epub 2019 Mar 26.
[Secondary biliary cirrhosis].
Ohsuga M, Zhang XJ, Aramaki T.
Ryoikibetsu Shokogun Shirizu. 1995;(7):200-2.
Biliary cirrhosis.
ALLEN AW, SCHATZKI R, et al.
N Engl J Med. 1947 Jan 23;236(4):148-51. doi: 10.1056/NEJM194701232360406.
Giant caudate lobe in secondary biliary cirrhosis.
de Hemptinne A, Husson T, Azoulay D.
J Gastrointest Surg. 2024 Jun;28(6):1000-1002. doi: 10.1016/j.gassur.2024.02.031. Epub 2024 Feb 21.
Common Bile Duct Ligation as Model for Secondary Biliary Cirrhosis.
Van Campenhout S, Van Vlierberghe H, Devisscher L.
Methods Mol Biol. 2019;1981:237-247. doi: 10.1007/978-1-4939-9420-5_15.
[Primary biliary cirrhosis].
Cecere A, Caiazzo R, Romano C, Gattoni A.
Clin Ter. 1998 Mar-Apr;149(2):143-50.
Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC.
Liu BD, Qureshi K.
Dig Dis Sci. 2023 Feb;68(2):346-348. doi: 10.1007/s10620-022-07661-y. Epub 2022 Sep 13.
Single-Center Experience of Living Donor Liver Transplantation for Patients With Secondary Biliary Cirrhosis.
Chang JG, Yoon YI, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Park JI.
Transplant Proc. 2021 Jan-Feb;53(1):98-103. doi: 10.1016/j.transproceed.2020.10.044. Epub 2020 Dec 16.
Secondary biliary cirrhosis. A limiting factor in the treatment of hepatolithiasis.
Jeng KS, Shih SC, Chiang HJ, Chen BF.
Arch Surg. 1989 Nov;124(11):1301-5. doi: 10.1001/archsurg.1989.01410110059012.
